Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
NWBOCompany Name
NORTHWEST BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
OTCNORTHWEST BIOTHERAPEUTICS INC - Enterprise Value over EBITDA Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NWBO - EV/EBITDA Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | Enterprise Value | Enterprise Value over EBITDA |
|---|---|---|---|
| 6/30/2025 | $ -72.28M | $ 416.81M | 0 |
| 3/31/2025 | $ -74.92M | $ 483.16M | 0 |
| 12/31/2024 | $ -73.97M | $ 385.14M | 0 |
| 9/30/2024 | $ -65.99M | $ 464.09M | 0 |
| 6/30/2024 | $ -65.64M | $ 427.16M | 0 |
| 3/31/2024 | $ -62.69M | $ 636.19M | 0 |
| 12/31/2023 | $ -55.63M | $ 711.01M | 0 |
| 9/30/2023 | $ -65.06M | $ 1.06B | 0 |
| 6/30/2023 | $ -79.61M | $ 589.87M | 0 |
| 3/31/2023 | $ -94.54M | $ 658.76M | 0 |
Key Performance Insights, Last 5 Years
- NORTHWEST BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) EV/EBITDA stands at 0.
- Over the past 5 years, NORTHWEST BIOTHERAPEUTICS INC's average EV/EBITDA has been 6.5.
- The median EV/EBITDA for NORTHWEST BIOTHERAPEUTICS INC during this period was 4.85
- NORTHWEST BIOTHERAPEUTICS INC reached its highest EV/EBITDA over the past 5 years at 11.79.
- The lowest EV/EBITDA recorded by NORTHWEST BIOTHERAPEUTICS INC in the same timeframe 4.51
NORTHWEST BIOTHERAPEUTICS INC's EV/EBITDA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV/EBITDA Benchmarks
Similar metrics to EV/EBITDA:
- Enterprise Value over EBIT - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
- Enterprise Value - [Calculation] Enterprise value (EV) refers to the total value of a business and is frequently used as a more elaborate substitute for market capitalization. EV is calculated as a company's [MarketCap] plus its [Debt] minus cash and cash equivalents [CashnEq].
- Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) - [Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
Definition of Enterprise Value over EBITDA
[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].EV / EBITDA
(=) EV/EBITDA EV/EBITDA for NORTHWEST BIOTHERAPEUTICS INC is calculated as follows: EV [ $ 1.13B ] / EBITDA [ $ -235.19M ]
(=) EV/EBITDA [ 0 ] NWBO - Enterprise Value over EBITDA, Last 5 years
4.51
Minimum
Mar 31, 2022
11.79
Maximum
Sep 30, 2022
6.5
Average
4.85
Median
EV/EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EV/EBITDA for companies in the Total Stock Market. The average EV/EBITDA of the companies is 13.48 with a standard deviation of 7.65.
The following table provides additional summary stats:
EV/EBITDA in the Market:
| filtered constituents | 2.44K |
|---|---|
| min | 0.01 |
| max | 40.82 |
| average | 13.48 |
| median | 11.75 |
| std | 7.65 |